This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Smith, C. C.
Right arrow Articles by Aurelian, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Smith, C. C.
Right arrow Articles by Aurelian, L.

 Previous Article  |  Next Article 

Journal of Virology, November 1998, p. 9131-9141, Vol. 72, No. 11
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

The PK Domain of the Large Subunit of Herpes Simplex Virus Type 2 Ribonucleotide Reductase (ICP10) Is Required for Immediate-Early Gene Expression and Virus Growth

C. C. Smith,1 T. Peng,1,dagger M. Kulka,1 and L. Aurelian1,2,*

Virology/Immunology Laboratories1 and Departments of Pharmacology and Experimental Therapeutics and Microbiology,2 University of Maryland School of Medicine, Baltimore, Maryland 21201

Received 30 March 1998/Accepted 7 July 1998

The large subunit of herpes simplex virus (HSV) ribonucleotide reductase (RR), RR1, contains a unique amino-terminal domain which has serine/threonine protein kinase (PK) activity. To examine the role of the PK activity in virus replication, we studied an HSV type 2 (HSV-2) mutant with a deletion in the RR1 PK domain (ICP10Delta PK). ICP10Delta PK expressed a 95-kDa RR1 protein (p95) which was PK negative but retained the ability to complex with the small RR subunit, RR2. Its RR activity was similar to that of HSV-2. In dividing cells, onset of virus growth was delayed, with replication initiating at 10 to 15 h postinfection, depending on the multiplicity of infection. In addition to the delayed growth onset, virus replication was significantly impaired (1,000-fold lower titers) in nondividing cells, and plaque-forming ability was severely compromised. The RR1 protein expressed by a revertant virus [HSV-2(R)] was structurally and functionally similar to the wild-type protein, and the virus had wild-type growth and plaque-forming properties. The growth of the ICP10Delta PK virus and its plaque-forming potential were restored to wild-type levels in cells that constitutively express ICP10. Immediate-early (IE) genes for ICP4, ICP27, and ICP22 were not expressed in Vero cells infected with ICP10Delta PK early in infection or in the presence of cycloheximide, and the levels of ICP0 and p95 were significantly (three- to sevenfold) lower than those in HSV-2- or HSV-2(R)-infected cells. IE gene expression was similar to that of the wild-type virus in cells that constitutively express ICP10. The data indicate that ICP10 PK is required for early expression of the viral regulatory IE genes and, consequently, for timely initiation of the protein cascade and HSV-2 growth in cultured cells.


* Corresponding author. Mailing address: Virology/Immunology Laboratories, University of Maryland School of Medicine, 10 S. Pine St., Baltimore, MD 21201. Phone: (410) 706-3895. Fax: (410) 706-2513. E-mail: laurelia{at}umaryland.edu.

dagger Present address: Department of Microbiology, School of Medicine. University of Pennsylvania, Philadelphia, Pa.


Journal of Virology, November 1998, p. 9131-9141, Vol. 72, No. 11
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Aurelian, L. (2004). Herpes Simplex Virus Type 2 Vaccines: New Ground for Optimism?. CVI 11: 437-445 [Abstract] [Full Text]  
  • Wales, S. Q., Smith, C. C., Wachsman, M., Calton, G., Aurelian, L. (2004). Performance and Use of a Ribonucleotide Reductase Herpes Simplex Virus Type-Specific Serological Assay. CVI 11: 42-49 [Abstract] [Full Text]  
  • Patrone, M., Percivalle, E., Secchi, M., Fiorina, L., Pedrali-Noy, G., Zoppe, M., Baldanti, F., Hahn, G., Koszinowski, U. H., Milanesi, G., Gallina, A. (2003). The human cytomegalovirus UL45 gene product is a late, virion-associated protein and influences virus growth at low multiplicities of infection. J. Gen. Virol. 84: 3359-3370 [Abstract] [Full Text]  
  • Perkins, D., Pereira, E. F. R., Aurelian, L. (2002). The Herpes Simplex Virus Type 2 R1 Protein Kinase (ICP10 PK) Functions as a Dominant Regulator of Apoptosis in Hippocampal Neurons Involving Activation of the ERK Survival Pathway and Upregulation of the Antiapoptotic Protein Bag-1. J. Virol. 77: 1292-1305 [Abstract] [Full Text]  
  • Perkins, D., Pereira, E. F. R., Gober, M., Yarowsky, P. J., Aurelian, L. (2002). The Herpes Simplex Virus Type 2 R1 Protein Kinase (ICP10 PK) Blocks Apoptosis in Hippocampal Neurons, Involving Activation of the MEK/MAPK Survival Pathway. J. Virol. 76: 1435-1449 [Abstract] [Full Text]  
  • Smith, C. C., Nelson, J., Aurelian, L., Gober, M., Goswami, B. B. (2000). Ras-GAP Binding and Phosphorylation by Herpes Simplex Virus Type 2 RR1 PK (ICP10) and Activation of the Ras/MEK/MAPK Mitogenic Pathway Are Required for Timely Onset of Virus Growth. J. Virol. 74: 10417-10429 [Abstract] [Full Text]  
  • Chen, M.-R., Chang, S.-J., Huang, H., Chen, J.-Y. (2000). A Protein Kinase Activity Associated with Epstein-Barr Virus BGLF4 Phosphorylates the Viral Early Antigen EA-D In Vitro. J. Virol. 74: 3093-3104 [Abstract] [Full Text]  
  • Sun, Y., Conner, J. (1999). The U28 ORF of human herpesvirus-7 does not encode a functional ribonucleotide reductase R1 subunit. J. Gen. Virol. 80: 2713-2718 [Abstract] [Full Text]  
  • Smith, C. C., Yu, Y. X., Kulka, M., Aurelian, L. (2000). A Novel Human Gene Similar to the Protein Kinase (PK) Coding Domain of the Large Subunit of Herpes Simplex Virus Type 2 Ribonucleotide Reductase (ICP10) Codes for a Serine-Threonine PK and Is Expressed in Melanoma Cells. J. Biol. Chem. 275: 25690-25699 [Abstract] [Full Text]